New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
11:51 EDTAAL, GILDStocks with call strike movement; AAL GILD
American Airlines (ALL) August 44 call option implied volatility increased 4% to 39, Gilead (GILD) August 80 call option implied volatility decreased 2% to 34 according to IVolatility.
News For AAL;GILD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 11, 2014
09:06 EDTAALAmerican Airlines adding Gogo inflight wireless to nearly 250 jets by 2016
07:54 EDTGILDGilead shares poised to continue to advance, says RBC Capital
Subscribe for More Information
December 10, 2014
17:21 EDTAALAmerican Airlines, United Continental can reach new highs, Barron's says
Subscribe for More Information
15:59 EDTGILDGilead sued by SEPTA over price of Hep C drug Sovaldi, WSJ reports
Subscribe for More Information
10:00 EDTAALOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:23 EDTAALOn The Fly: Pre-market Movers
Subscribe for More Information
08:52 EDTAALBoeing delivery of first 787 to American delayed again, Dallas News reports
Subscribe for More Information
06:00 EDTAALBarclays upgrades United, American amid lower oil prices
Subscribe for More Information
05:39 EDTAALUnited Continental upgraded to Overweight from Underweight at Barclays
Barclays upgraded United Continental (UAL) two notches to Overweight from Underweight citing the benefits from lower oil prices. The firm raised its price target for shares to $76 from $52. The airliner closed yesterday down $1.73 to $62.52. Barclays also upgraded American Airlines (AAL) this morning to Overweight. Its top picks in the space are Spirit Airlines (SAVE), then American and United, followed by Delta Air Lines (DAL) and Southwest (LUV). It now has Overweight ratings on all four major U.S. airlines.
05:34 EDTAALAmerican Airlines upgraded to Overweight from Equal Weight at Barclays
Subscribe for More Information
December 9, 2014
09:38 EDTGILDActive equity options trading
Subscribe for More Information
08:38 EDTGILDGilead price target raised to $130 from $110 at Argus
Subscribe for More Information
December 8, 2014
16:00 EDTGILDOptions Update; December 8, 2014
Subscribe for More Information
10:02 EDTGILDGilead presents follow-up data from Zydelig registrational studies
Subscribe for More Information
08:04 EDTAALAmerican Airlines reports November revenue passenger miles down 0.5% to 16.2B
American Airlines's total revenue passenger miles for the month were 16.2B, down 0.5% versus November 2013. Total capacity was 20.8B available seat miles, up 0.9% versus November 2013. Total passenger load factor was 77.7% for the month of November, down 1.1 points versus November 2013. The company expects its fourth quarter consolidated passenger revenue per available seat mile to be approximately down one percent to up 1%. In addition, the company continues to expect its fourth quarter pretax margin excluding special charges to be approximately 10%-12%.
December 5, 2014
09:36 EDTGILDActive equity options trading
Subscribe for More Information
07:37 EDTGILDGilead price target raised to $121 from $110 at JPMorgan
JPMorgan raised its price target for Gilead shares to $121 saying the company's potential cash flow generation is "immense" and provides "significant strategic flexibility." The firm estimates Gilead can generate more than $30B in cash in the next two years and $80B-plus over the next five years. It keeps an Overweight rating on the stock.
December 4, 2014
10:18 EDTAALAirline stocks lifted following JPMorgan valuation call
Subscribe for More Information
09:01 EDTGILDVA negotiated $594 per dose price for Gilead HCV treatment
A Veterans Health Administration official told a Senate committee yesterday that Veterans' Affairs has "moved rapidly to deploy new, more effective, less toxic HCV treatments and has been able to negotiate significant discounts for these newer therapies." The agency negotiated a price of $594 per dose for Gilead's (GILD) Hepatitis C virus drug Sofosbuvir, below the commercial price of $1,000 per dose, VHA Chief Consultant for Pharmacy Benefits Management Michael Valentino told the Senate's Committee on Veterans' Affairs. The agency also received a $413 per dose price for Johnson & Johnson's (JNJ) Simeprevir, below the commerical price of $790. The VA has approximately 174,000 veterans in care with HCV, making it the largest single HCV provider in the U.S., Valentino pointed out. He added, "Like the rest of the country, VA has treated only a portion of Veterans for HCV because treatment and cures have been difficult to achieve due to low efficacy and high toxicity of standard drug therapies." Reference Link
07:26 EDTAALJPMorgan says Airlines more attractive today than two months ago
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use